Evidence map›Paper›PMID 38792852›Full record

ArticleMicroorganisms2024

Interplay of Demographic Influences, Clinical Manifestations, and Longitudinal Profile of Laboratory Parameters in the Progression of SARS-CoV-2 Infection: Insights from the Saudi Population.

Sarah Al-Hassinah, Sooad Al-Daihan, Mashael Alahmadi, Sara Alghamdi, Rawabi Almulhim, Dalia Obeid, Yaseen Arabi, Abdulrahman Alswaji, Marwh Aldriwesh, Majed Alghoribi

Abstract read
In one paragraph

Article in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sarah Al-HassinahInfectious Diseases Research Department, King Abdullah International Medical Research Center, Riyadh 11426, Saudi Arabia.ORCID 0000-0003-0942-235X
Sooad Al-DaihanBiochemistry Department, College of Science, King Saud University, Riyadh 11495, Saudi Arabia.
Mashael AlahmadiResearch Office, Saudi National Institute of Health (SNIH), Riyadh 12382, Saudi Arabia.ORCID 0000-0002-4734-3049
Sara AlghamdiInfectious Diseases Research Department, King Abdullah International Medical Research Center, Riyadh 11426, Saudi Arabia.
Rawabi AlmulhimInfection Prevention and Control Department, King Abdulaziz Medical City, Riyadh 14611, Saudi Arabia.
Dalia ObeidKing Faisal Specialist Hospital and Research Center, Riyadh 11564, Saudi Arabia.ORCID 0000-0003-0251-1894
Yaseen ArabiInfectious Diseases Research Department, King Abdullah International Medical Research Center, Riyadh 11426, Saudi Arabia.
Abdulrahman AlswajiInfectious Diseases Research Department, King Abdullah International Medical Research Center, Riyadh 11426, Saudi Arabia.ORCID 0000-0003-1713-9335
Marwh AldriweshInfectious Diseases Research Department, King Abdullah International Medical Research Center, Riyadh 11426, Saudi Arabia.ORCID 0000-0001-6319-2669
Majed AlghoribiInfectious Diseases Research Department, King Abdullah International Medical Research Center, Riyadh 11426, Saudi Arabia.ORCID 0000-0002-2122-8640

Funding

King Abdullah International Medical Research Center RC16/094/R
6 · The paper itself

Abstract

Understanding the factors driving SARS-CoV-2 infection progression and severity is complex due to the dynamic nature of human physiology. Therefore, we aimed to explore the severity risk indicators of SARS-CoV-2 through demographic data, clinical manifestations, and the profile of laboratory parameters. The study included 175 patients either hospitalized at King Abdulaziz Medical City-Riyadh or placed in quarantine at designated hotels in Riyadh, Saudi Arabia, from June 2020 to April 2021. Hospitalized patients were followed up through the first week of admission. Demographic data, clinical presentations, and laboratory results were retrieved from electronic patient records. Our results revealed that older age (OR: 1.1, CI: [1.1-1.12];

Indexed as

ageclinical manifestationscomorbiditygenderlaboratory parametersrisk factorsSARS-CoV-2 infectionseverity progression

Identifiers

PMID38792852
PMCPMC11124088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.